Vincent Milano Biocryst Pharmaceuticals Inc (BCRX) insider trading activity

Vincent Milano is Director of BIOCRYST PHARMACEUTICALS INC. Currently has a direct ownership of 91,219 shares of BCRX, which is worth approximately $645,830. The most recent transaction as insider was on Nov 28, 2025, when has been sold 783 shares (Common Stock) at a price of $7.18 per share, resulting in proceeds of $5,621. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 91.2K

0.87% 3M change

19.89% 12M change

Total Value Held $645,830

VINCENT MILANO Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 28 2025	BUY Grant, award, or other acquisition	$5,621 $7.18 p/Share	783 Added 0.85%	91,219 Common Stock
Aug 29 2025	BUY Grant, award, or other acquisition	$5,617 $8.31 p/Share	676 Added 0.74%	90,436 Common Stock
Jun 12 2025	BUY Grant, award, or other acquisition	-	12,500 Added 12.22%	89,760 Common Stock
May 30 2025	BUY Grant, award, or other acquisition	$5,622 $10.75 p/Share	523 Added 0.67%	77,260 Common Stock
Feb 28 2025	BUY Grant, award, or other acquisition	$5,622 $8.61 p/Share	653 Added 0.84%	76,737 Common Stock
Nov 29 2024	BUY Grant, award, or other acquisition	$5,625 $7.5 p/Share	750 Added 0.98%	76,084 Common Stock
Aug 30 2024	BUY Grant, award, or other acquisition	$5,622 $8.69 p/Share	647 Added 0.85%	75,334 Common Stock

Jun 12 2024	BUY Grant, award, or other acquisition	-	6,820 Added 8.37%	74,687 Common Stock
May 31 2024	BUY Grant, award, or other acquisition	$5,620 $6.46 p/Share	870 Added 1.27%	67,867 Common Stock
May 20 2024	BUY Open market or private purchase	$93,750 $6.25 p/Share	15,000 Added 18.29%	66,997 Common Stock
Feb 29 2024	BUY Grant, award, or other acquisition	$5,624 $5.63 p/Share	999 Added 1.89%	51,997 Common Stock
Nov 30 2023	BUY Grant, award, or other acquisition	$5,621 $5.88 p/Share	956 Added 1.84%	50,998 Common Stock
Aug 31 2023	BUY Grant, award, or other acquisition	$5,624 $7.11 p/Share	791 Added 1.56%	50,042 Common Stock
Jun 13 2023	BUY Grant, award, or other acquisition	-	16,745 Added 25.37%	49,251 Common Stock
May 31 2023	BUY Grant, award, or other acquisition	$5,623 $8.27 p/Share	680 Added 2.05%	32,506 Common Stock
Feb 28 2023	BUY Grant, award, or other acquisition	$5,619 $8.85 p/Share	635 Added 1.96%	31,826 Common Stock
Nov 30 2022	BUY Grant, award, or other acquisition	$5,624 $13.36 p/Share	421 Added 1.33%	31,191 Common Stock
Aug 31 2022	BUY Grant, award, or other acquisition	$5,616 $13.9 p/Share	404 Added 1.3%	30,770 Common Stock
Jun 07 2022	BUY Grant, award, or other acquisition	-	12,866 Added 29.76%	30,366 Common Stock
Nov 24 2021	BUY Open market or private purchase	$91,425 $12.19 p/Share	7,500 Added 30.0%	17,500 Common Stock

Also insider at

IDRA

IDERA PHARMACEUTICALS, INC. Healthcare

ACRS

Aclaris Therapeutics, Inc. Healthcare

Vincent Milano

Director

Exton, PA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BCRX shares.

Notify only if

Value

Insider Trading

Get notified when an Biocryst Pharmaceuticals Inc insider buys or sells BCRX shares.

Notify only if

Operation

Value

Type

News

Receive news related to BIOCRYST PHARMACEUTICALS INC

Track Activities on BCRX

Account